Literature DB >> 216440

In vitro platelet abnormality in adenosine deaminase deficiency and severe combined immunodeficiency.

C H Lee, S P Evans, M C Rozenberg, A S Bagnara, J B Ziegler, M B Van der Weyden.   

Abstract

The platelets of an infant with severe combined immune deficiency and adenosine deaminase deficiency showed markedly diminished responses to ADP-induced aggregation in vitro. This abnormality was corrected by the addition of purified adenosine deaminase in vitro. Exogenous adenosine added to platelet-rich plasma caused markedly prolonged inhibition of ADP-induced aggregation. This was shown by isotopic studies to be due to slow clearance of adenosine and hence persistence of this nucleoside. Direct assay for adenosine deaminiase in plasma and platelet lysates of the patient confirmed the very low activity of this enzyme. Raised cAMP levels were demonstrated in his platelets. The deranged adenosine metabolism and raised cAMP in the platelets of this child with severe combined immunodeficiency may explain the altered response to ADP. Despite the in vitro platelet aggregation abnormality, the patient had no clinical evidence of impaired hemostasis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216440

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Antigenicity of UV radiation-induced murine tumors correlates positively with the level of adenosine deaminase activity.

Authors:  S L Aukerman; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapy.

Authors:  J B Ziegler; C H Lee; M B Van der Weyden; A S Bagnara; J Beveridge
Journal:  Arch Dis Child       Date:  1980-06       Impact factor: 3.791

3.  Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.

Authors:  G Morgan; R J Levinsky; K Hugh-Jones; L D Fairbanks; G S Morris; H A Simmonds
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

Review 4.  Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.

Authors:  Nina Wolska; Marcin Rozalski
Journal:  Int J Mol Sci       Date:  2019-11-03       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.